mRNA Vaccine for Influenza in Healthy Adults
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Recruiting
Phase 2
Interventional Study
Healthy Adults
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 770 (estimated)
- Sponsor
- Pfizer · Industry
Who this trial is looking for
This trial is looking for healthy adults aged 18 and older to learn about a new flu vaccine. Participants will receive one dose of the vaccine and will be involved for about 6 months, with three study visits required.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I am healthy and medically stable
You may not be able to join if
- I tested positive for influenza in the last 5 months
- I received any flu vaccine in the last 5 months
- I was given antiviral flu medications in the last 5 months
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to learn about safety in participants taking the study vaccine (mRNA-based vaccine) and the ability of the study vaccine to trigger the body's immune response, targeting the flu virus (influenza virus).
This study is seeking healthy participants 18 years of age or older. All participants in this study will receive only 1 dose in their arm, to deliver one of the experi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
• Healthy and medically stable participants who are determined by medical history, physical examination (if clinically required), and clinical judgment of the investigator to be eligible for inclusion in the study.
Exclusion Criteria
* Tested positive for influenza ≤5 months (1…
Contacts